Sonnet BioTherapeutics (SONN) Debt to Equity (2010 - 2025)
Sonnet BioTherapeutics (SONN) debt to equity from Dec 31, 2010 to Sep 30, 2025. The current Sonnet BioTherapeutics (SONN) debt to equity is 0.00%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Sonnet BioTherapeutics (SONN)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 0.00% | N/A |
| 2024 | 0.00% | N/A |
| 2023 | 0.00% | N/A |
| 2022 | 0.00% | N/A |
| 2021 | 0.00% | N/A |
| 2020 | 0.00% | -100.00% |
| 2019 | -367.31% | N/A |
| 2019 | 0.00% | -100.00% |
| 2018 | 89.64% | N/A |
| 2018 | 0.00% | -100.00% |
| 2017 | 107.19% | N/A |
| 2017 | 0.00% | N/A |
| 2017 | 0.00% | -100.00% |
| 2016 | 51.43% | +69.62% |
| 2015 | 30.32% | -33.44% |
| 2014 | 45.56% | +316.32% |
| 2013 | 10.94% | +152.15% |
| 2012 | 4.34% | -98.49% |
| 2011 | 287.76% | -56.88% |
| 2011 | 667.35% | -43.20% |
| 2010 | 1175.00% | N/A |
| 2010 | 1175.00% | N/A |